Wendi Zhan
Overview
Explore the profile of Wendi Zhan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
11
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tang Y, Hu H, Chen S, Hao B, Xu X, Zhu H, et al.
Sci Rep
. 2025 Mar;
15(1):8591.
PMID: 40074806
NAD(P)H dehydrogenase quinone 1 (NQO1) is overexpressed in various cancers and is strongly associated with an immunosuppressive microenvironment and poor prognosis. In this study, we explored the role of NQO1...
2.
Zhu H, Hu H, Hao B, Zhan W, Yan T, Zhang J, et al.
Technol Cancer Res Treat
. 2024 Aug;
23:15330338241263434.
PMID: 39205467
Background: Breast cancer is a prevalent public health concern affecting numerous women globally and is associated with palmitoylation, a post-translational protein modification. Despite increasing focus on palmitoylation, its specific implications...
3.
Hu H, Zhu H, Zhan W, Hao B, Yan T, Zhang J, et al.
Inflamm Res
. 2024 Apr;
73(6):1047-1068.
PMID: 38622285
Background: Tumor immunotherapy brings new light and vitality to breast cancer patients, but low response rate and limitations of therapeutic targets become major obstacles to its clinical application. Recent studies...
4.
Zhan W, Hu H, Hao B, Zhu H, Yan T, Zhang J, et al.
Heliyon
. 2024 Mar;
10(5):e27507.
PMID: 38463870
Background: Malignant pericardial effusion (MPE) is a common complication of advanced breast cancer (BRCA) and plays an important role in BRCA. This study is aims to construct a prognostic model...
5.
Zhang T, Zhu H, Hu H, Hu H, Zhan W, Jiang L, et al.
Prev Med
. 2023 Dec;
179:107796.
PMID: 38070711
Background: Colorectal cancer (CRC) is one of the most common cancers worldwide, and recent studies have found that CRC patients are at increased risk for cardiovascular disease (CVD). This study...
6.
Hu H, Zou M, Hu H, Hu Z, Jiang L, Escobar D, et al.
NPJ Precis Oncol
. 2023 Dec;
7(1):130.
PMID: 38066053
This study sought to identify molecular subtypes of breast cancer (BC) and develop a breast cancer stem cells (BCSCs)-related gene risk score for predicting prognosis and assessing the potential for...
7.
Hu H, Yan T, Zhu H, Zhan W, Zhang J, Wang S, et al.
Clin Exp Med
. 2023 Nov;
23(8):5139-5159.
PMID: 37930605
Breast cancer is one of the most prevailing forms of cancer globally. Immunotherapy has demonstrated efficacy in improving the overall survival of breast cancer. The aim of us was to...
8.
Tang L, Lei X, Hu H, Li Z, Zhu H, Zhan W, et al.
Transl Oncol
. 2023 May;
34:101700.
PMID: 37247503
Breast cancer (BRCA) is a major global health issue, characterized by high mortality and low early diagnosis rates. The tumor immune microenvironment (TME) of BRCA is closely linked to fatty...
9.
Hu H, Wang H, Yang X, Li Z, Zhan W, Zhu H, et al.
Sci Rep
. 2023 May;
13(1):7623.
PMID: 37165049
Breast cancer and diabetes are significant health challenges, and effective treatments for both diseases are lacking. Proton pump inhibitors (PPIs) have demonstrated anticancer and hypoglycemic effects, but their mechanisms of...